![Xiao Tian Zhu](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Oorsprong van het eerstegraads netwerk van Xiao Tian Zhu
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
QILU Regor Therapeutics, Inc.
3
| Private Company | 3 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Xiao Tian Zhu via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
Regor Therapeutics Group
![]() Regor Therapeutics Group Miscellaneous Commercial ServicesCommercial Services Regor Therapeutics Group is a biotech company founded in 2018 by a team of scientists with expertise in drug discovery and development. The company is based in Boston, MA and has subsidiaries in China. Regor Therapeutics Group utilizes its industry-leading core strength in Rcard™ to accelerate the discovery of innovative therapeutic agents. The company has completed 8 PCCs in-house, with 5 INDs filed, and has a pipeline of leading assets in metabolism, oncology, and auto-immunity. The company's two leading assets are RGT-075, an orally bioavailable small molecule GLP1R full agonist with potential for obesity and beyond, and RGT-419B, a unique CDK4+ inhibitor showing outstanding single agent responses in refractory ER+/HER2- breast cancer patients. The company was founded in 2018, and the CEO is Xiayang Qiu. | Miscellaneous Commercial Services | Chief Executive Officer Chief Operating Officer |
Statistieken
Internationaal
Verenigde Staten | 2 |
Sectoraal
Commercial Services | 2 |
Operationeel
Founder | 3 |
Chief Executive Officer | 2 |
Chief Operating Officer | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Sterkste connecties
Insiders | |
---|---|
Xiayang Qiu | 2 |
Min Zhong | 2 |
Wen Ge Zhong | 1 |
- Beurs
- Insiders
- Xiao Tian Zhu
- Bedrijfsconnecties